骨转移癌的^（153）Sm－EDTMP治疗评价  

CLINICAL ANALYSIS OF ￣(153)Sm-EDTMP THERAPY FOR METASTATIC BONE CANCER

作　　者：张青[1] 杨晓青[1] 贺之连[1] 未姺 熊立跃[1] 胡冬莲 

机构地区：[1]江西医学院第一附属医院ECT室

出　　处：《同位素》1995年第4期225-227,共3页Journal of Isotopes

摘　　要：分析了￣（１５３）Ｓｍ－ＥＤＴＭＰ治疗２４例骨转移癌的结果。经静脉给药，剂量为２５．９ＭＢｑ／ｋｇ，结果表明：￣（１５３）Ｓｍ－ＥＤＴＭＰ镇痛效果明显，总有效率达９１．６％，其中１０例经连续多次治疗，患者中４０％病灶出现消失，变淡改变。实践证明，￣（１５３）Ｓｍ－ＥＤＴＭＰ治疗骨转移癌，具有明显的临床价值。The therapeutic effect of ￣(153)Sm- EDTMP on 24 cases of metastatic bone cancer is analysed.￣(153)Sm-EDTMP is injected into the median cubital vein with a radioactive dose 25.9MBq/kg.The result shows that ￣(153)Sm-EDTMP relieved pain evidently and the total efficiency is 91.6%. In 10 of thepatients having received reported treatments,40% of the lesions disappeared or became obscure on radionuclide imaging.It is proved that the treatment of metastatic bone cancer with ￣(153)Sm-EDTMP is ofsignificant clinical value.

关 键 词：骨转移癌 显像 锶153 

分 类 号：R738.1[医药卫生—肿瘤] R817.508[医药卫生—临床医学]